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Abstract: In Europe, the alternative centrifuge method of liquid-based cytology is widely used 
in cervical screening. Turbitec® (Labonord SAS, Templemars, France) is a centrifuge method 
of liquid-based cytology using an alcoholic fixative fluid, Easyfix® (Labonord). It is now well 
accepted that the association of liquid-based cytology and human papillomavirus test is indis-
sociable of cervical screening. The aim of this work was to demonstrate that Easyfix alcoholic 
fluid is reliable to perform Hybrid Capture® 2 (QIAGEN SAS, Courtaboeuf, France). In this 
study, 75 patients with colposcopy for cervical lesions served as gold standard. A sample was 
collected, at random, for Easyfix fixative cytological fluid and for Digene Cervical Sampler 
(QIAGEN). The results of Hybrid Capture 2 (with relative light unit .1) showed no statistical 
difference, a positive Spearman’s correlation (r = 0.82, P , 0.0001), and a kappa value of 0.87 
(excellent agreement) between the two fluids. It was concluded that Easyfix is accurate to use 
in human papillomavirus tests with Hybrid Capture 2.
Keywords: human papillomavirus, hybrid capture 2, Turbitec®, cervix cytology, liquid-based 
cytology
Introduction
In Europe, the alternative method of manual liquid-based cytology (LBC) is 
widely used in cervical screening.1 The centrifuge method is the most common, for 
example the Turbitec® system (Labonord SAS, Templemars, France) of LBC, 
which uses a nonbuffered solution containing about 25% of ethylic alcohol and 
ethylenediaminetetraacetic acid (Easyfix®; Labonord).
It is now well accepted that the association of LBC and human papillomavirus 
(HPV) test is indissociable of the screening for HPV-related cervical lesions, espe-
cially for atypical squamous cells of undetermined significance cytological lesions.2 
One of the most common HPV tests is Hybrid Capture® 2 (HC2; QIAGEN SAS, 
Courtaboeuf, France).
The aim of this work was to demonstrate that Easyfix fluid is technically reliable 
to use with HC2.
Material and methods
Colposcopies or conizations were performed on 75 women (age 35.7 ± 10.8 years). 
The final diagnosis was classified into four groups: within the normal limits (WNL) 
or no lesion (n = 13), cervical intraepithelial neoplasia grade 1 (CIN1, n = 6), grade 2 
(CIN2, n = 21), and grade 3 (CIN3, n = 35). Colposcopy without biopsy but with 
cytology was performed in eight WNL that were negative for HPV and had no HPV 
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history. The 61 CIN patients and five other WNL patients 
had a biopsy.
At time of colposcopy, a cervix sample was collected, at 
random, for Easyfix fixative cytological fluid and for Digene 
Cervical Sampler (QIAGEN). Both fluids were sent to two 
different independent laboratories in France (n = 54) and in 
Belgium (n = 21). HC2 assay on Cervical Sampler was made 
according to the manufacturer’s instructions.
The HC2 assay on Easyfix was performed in 4 mL of 
residual Easyfix added to 400 µL Sample Conversion Buffer 
(QIAGEN). The solution was pelleted at 4000 rpm for 
20 minutes. The supernatant was discarded. The cellular 
pellet was resuspended with 150 µL denaturation solution 
(composed of Specimen Transport Medium™ and Denatur-
ation Reagent; QIAGEN).
Classical hybridization, detection, and calibration were 
made according to the HC2 kit instructions. Probes were 
used only against the high-risk HPV genotypes: 16, 18, 31, 
33, 35, 39, 45, 51, 52, 56, 58, 59, and 68. The HC2 results 
were expressed as positive or negative, with relative light 
unit (RLU) .1 as a positive result.3
As negative controls, five samples each of Cervical Sam-
pler and Easyfix alone were used. These were performed 
using the same HC2 methodology.
The results were expressed by percentage of observations 
or mean ± standard deviation. The results of the colposcopy 
and biopsy served as gold standard.
Fisher’s exact test, McNemar’s test, Spearman’s rank 
correlation, and Cohen’s kappa test were performed. 
P , 0.05 was considered significant. In general, a kappa 
value higher than 0.75 indicates excellent agreement. 
Analyse-it® 2.22 (Analyse-it Software Ltd, Leeds, United 
Kingdom) and Excel 2003 (Microsoft Corporation,  Redmond, 
WA) were used for statistical analysis.
Results
A significant difference in age was observed between WLN 
(43.2 ± 12.1 years) and CIN lesions (CIN1 = 30.2 ± 4.0 years; 
CIN2 = 32.0 ± 9.7 years; CIN3 = 35.5 ± 10.4 years).
All samples were fixed 13.1 ± 13.9 days before the 
HC2 test.
Table 1 shows HC2 results when RLU was .1. No sta-
tistical difference was found with McNemar’s test, showing 
that the two methods were similar.
Three cases were discrepant: one false positive for 
Cervical Sampler in WLN (RLU 0.18 for Easyfix versus 
19.7 for Cervical Sampler) and two false negatives – CIN2 
and Cervical Sampler (RLU 318.8 versus 0.45); CIN3 and 











Notes: No statistical difference was observed. easyfix® came from Labonord SAS 
(Templemars, France) and Cervical Sampler from QIAGeN SAS (Courtaboeuf, France). 
Abbreviations: CIN, cervical intraepithelial neoplasia; WLN, within the normal 






Figure 1 easyfix® (Labonord SAS, Templemars, France): comparison of relative 
light units following colposcopic diagnosis.
Note: Relative light units exponentially increased following patients groups.
Abbreviations: CIN, cervical intraepithelial neoplasia; WLN, within the normal 
limits or no lesion.
Easyfix (RLU 0.12 versus 15.32). It must be noted that 
RLU were always low, probably because samples had low 
viral concentration.
HC2 results when RLU was .1 showed a positive 
 Spearman’s correlation with r = 0.82 (P , 0.0001). A kappa 
value of 0.87 showed excellent agreement between the two 
fluids.
Figures 1 and 2 show that RLU exponentially increased 
following patient groups: WLN, 1.6 ± 5.2 versus 0.18 ± 0.04 
(P = no significance); CIN1, 17.9 ± 71.5 versus 182.7 ± 314.8 
(P = no signif icance); CIN2, 215.3 ± 468.2 versus 
484.3 ± 684.9 (P = 0.004); and CIN3, 445.8 ± 734.7 versus 
721.8 ± 625.4 (P = 0.002) for Cervical Sampler and Easyfix, 
respectively. Thus, RLU of Easyfix increased faster than 
Cervical Sampler. Negative controls showed an RLU 
0.24 ± 0.14 versus 0.60 ± 0.21 for Cervical Sampler and 
Easyfix, respectively (data not shown).
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Discussion
This work compared HPV/HC2 test using Easyfix cytologi-
cal liquid fixative with Cervical Sampler. There was no 
statistical difference between these two fluids; Spearman’s 
correlation was r = 0.85 and a kappa value of 0.87 showed 
excellent agreement.
Curiously, HC2 values using Easyfix were higher than 
those with Cervical Sampler, likely due to difference in the 
sampling – the Rovers® Cervex-Brush® (Rovers Medical 
Devices BV, Oss, The Netherlands) gave more cells or HPV/
DNA in the Easyfix fluid. Both fluids showed a false positive 
(1/75 [1.3%] for Cervical Sampler versus 0/75 for Easyfix) 
or false negative (1/75 [1.3%] for Cervical Sampler versus 
1//75 [1.3%] for Easyfix) test. Interestingly, RLU were also 
lower than true results, likely corresponding with cases with 
lower DNA viral concentration. One case of CIN1 was both 
negative for Cervical Sampler and Easyfix, likely because 
HPV type was not tested by high-risk HC2 probes.
The aim of this study was to demonstrate the accuracy 
of Easyfix for HC2 method. Due to case selection, the results 
cannot be interpreted as an epidemiological study; therefore, 
results of sensitivity or specificity are not accurate.
In Europe, Easyfix is widely used with the low-cost 
liquid-based method Turbitec. Turbitec is an alternative 
method to automated and more expensive LBC methods. In 
2000, Johnson et al4 described a similar method of LBC using 
a Hettich cytocentrifuge (Andreas Hettich GmbH, Tuttlingen, 
Germany). Garbar et al5 was the first to demonstrate that 
Turbitec LBC had the same efficiency of LBC methods 
approved by United States Food and Drug Administration. 
More recently, Van Hemel et al6 demonstrated the efficiency 
of Turbitec in 632 colposcopies. It is now well accepted that 
the association of LBC and HPV test is indissociable of the 
screening of HPV-related cervical lesions, especially for 
atypical squamous cells of undetermined significance cyto-
logical lesions.2 The adequacy of fixative fluid to perform 
HPV tests is thus vital.
In 2004, Leduc et al,7 with a comparative study of Cervical 
Sampler in 256 samples, were the first to demonstrate the 
feasibility of performing HC2 with Easyfix. They found a kappa 
value of 0.76; lower than the kappa value in the present study. 
However, it must be noted that the methodology of sample 
preparation for HC2 was not the same in both studies, ie, 1.5 mL 
of Easyfix versus 4 mL used in the present study.
In 2005, a comparative study between HC2 and a poly-
merase chain reaction (PCR) technique, using QIAamp DNA 
Blood Mini Kit (QIAGEN) in 72 samples fixed with Easyfix, 
showed a kappa value of 0.89, similar to the present results.4 
Interestingly, even after 3.2 ± 0.9 months at room temperature 
the stability of DNA tested by beta globin was excellent.
INNO-LiPA HPV Genotyping Extra (Innogenetics NV, 
Gent, Belgium) is a new promising method that could be 
applied on cervical cell specimens.8 In 2007, Fontaine et al9 
compared PCR sequencing, INNO-LiPA, and HC2 in 
162 samples fixed with Easyfix. They demonstrated the 
stability of HPV-DNA for the three different methods (HC2 
and INNO-LiPA: kappa value 0.552; HC2 and PCR: kappa 
value 0.729; PCR and INNO-LiPA: kappa value 0.843), with 
kappa values similar to the present study.
Conclusion
The results demonstrated the stability of DNA in Easyfix 
alcoholic cytological fixative fluid and its accuracy in HPV 
tests with HC2.
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Figure 2 Cervical Sampler comparison of relative light units following colposcopic 
diagnosis.
Notes: Relative light units exponentially increased following patients groups. 
Relative light units for Cervical Sampler were lower than those for easyfix®.
Abbreviations: CIN, cervical intraepithelial neoplasia; WLN, within the normal 
limits or no lesion.
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